Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma

被引：0
|
作者：
Huimei Zhou
Qian Liu
Xiaohua Shi
Yue Liu
Dongyan Cao
Jiaxin Yang
机构：
[1] Peking Union Medical College Hospital,Department of Gynaecologic Oncology
[2] Peking Union Medical College Hospital,Department of Pathology
来源：
Journal of Ovarian Research | / 13卷
关键词：
Ovarian clear cell carcinoma; Gene expression profiles; High-grade serous ovarian carcinoma; Outcome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] High PTPN13 expression in high grade serous ovarian carcinoma is associated with a better patient outcome
    D'Hondt, Veronique
    Lacroix-Triki, Magalie
    Jarlier, Marta
    Boissiere-Michot, Florence
    Puech, Carole
    Coopman, Peter
    Katsaros, Dionyssios
    Freiss, Gilles
    ONCOTARGET, 2017, 8 (56) : 95662 - 95673
  • [32] Combination of TP53 and AGR3 to distinguish ovarian high-grade serous carcinoma from low-grade serous carcinoma
    Qiu, Chunping
    Wang, Yu
    Wang, Xiao
    Zhang, Qing
    Li, Yinuo
    Xu, Ying
    Jin, Chengjuan
    Bu, Hualei
    Zheng, Wenxin
    Yang, Xingsheng
    Lu, Nan
    Kong, Beihua
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (06) : 2041 - 2050
  • [33] Improving PARP inhibitor efficacy in high-grade serous ovarian carcinoma: A focus on the immune system
    Bound, Nirashaa T.
    Vandenberg, Cassandra J.
    Kartikasari, Apriliana E. R.
    Plebanski, Magdalena
    Scott, Clare L.
    FRONTIERS IN GENETICS, 2022, 13
  • [34] The MEK1/2 Pathway as a Therapeutic Target in High-Grade Serous Ovarian Carcinoma
    Chesnokov, Mikhail S.
    Khan, Imran
    Park, Yeonjung
    Ezell, Jessica
    Mehta, Geeta
    Yousif, Abdelrahman
    Hong, Linda J.
    Buckanovich, Ronald J.
    Takahashi, Akimasa
    Chefetz, Ilana
    CANCERS, 2021, 13 (06) : 1 - 20
  • [35] High-grade serous ovarian carcinoma, the “Achiles’ hill” for clinicians and molecular biologists: a molecular insight
    Rittwika Bhattacharya
    Arijit Ghosh
    Soma Mukhopadhyay
    Molecular Biology Reports, 2023, 50 : 9511 - 9519
  • [36] High-grade serous ovarian carcinoma, the "Achiles' hill" for clinicians and molecular biologists: a molecular insight
    Bhattacharya, Rittwika
    Ghosh, Arijit
    Mukhopadhyay, Soma
    MOLECULAR BIOLOGY REPORTS, 2023, 50 (11) : 9511 - 9519
  • [37] GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma
    El-Arabey, Amr Ahmed
    Denizli, Merve
    Kanlikilicer, Pinar
    Bayraktar, Recep
    Ivan, Cristina
    Rashed, Mohammed
    Kabil, Nashwa
    Ozpolat, Bulent
    Calin, George A.
    Salama, Salama Abdou
    Abd-Allah, Adel Rashad
    Sood, Anil K.
    Lopez-Berestein, Gabriel
    CELLULAR SIGNALLING, 2020, 68
  • [38] Predictive impact of clinical factors on chemosensitivity in advanced high-grade serous ovarian carcinoma according to chemotherapy response score
    Park, Mia
    Shin, Won Kyo
    Lim, Myong Cheol
    Park, Sang-Yoon
    Yoo, Chong Woo
    Kim, Kyung-Hee
    Suh, Kwang-Sun
    Yoo, Heon Jong
    MEDICINE, 2024, 103 (47)
  • [39] Intra-Tumoral Lymphocytic Infiltration Is Associated with Favorable Prognosis in Suboptimal Surgery in High-Grade Serous Ovarian Carcinoma
    Harada, Hiroshi
    Hachisuga, Toru
    Harada, Yoshikazu
    Shibahara, Mami
    Murakami, Midori
    Nuratdinova, Fariza
    Higami, Shota
    Tohyama, Atsushi
    Kinjo, Yasuyuki
    Ueda, Taeko
    Kurita, Tomoko
    Matsuura, Yusuke
    Nakayama, Toshiyuki
    Yoshino, Kiyoshi
    DIAGNOSTICS, 2025, 15 (04)
  • [40] Gene networks and expression quantitative trait loci associated with adjuvant chemotherapy response in high-grade serous ovarian cancer
    Choi, Jihoon
    Topouza, Danai G.
    Tarnouskaya, Anastasiya
    Nesdoly, Sean
    Koti, Madhuri
    Duan, Qing Ling
    BMC CANCER, 2020, 20 (01)
12345